hmmmmmmmm wrote: Shareholders were told for years that the 90/ Interim Enrollment would be a
"major catalyst for the company", but when the PR for 90 came it was the opposite.
Why?
The "major catalyst" was not about reaching an arbitrary number, it was to be driven by confirmation of positive trial results so far, and proof through the sharing of crude data.
It was the moment for Spectral to proudly reveal their work. To stop saying "we promise", but to show their cards to the market and say- "we told you so..."
We are now at 21 days since the 90th patient was enrolled. Next week management could do what they've promised so many times to shareholders - share the crude data and allow the market to react in the positive way they have repeatedly predicted and expect.
Since Oct...
Feb 5 2024
“enrollment milestone of 90 patients, which is expected to play as a major catalyst for the Company,” said Chris Seto
Jan 30 2024
“milestone of 90 patients, which is expected to play as a major catalyst for the Company,” said Chris Seto
Jan 10 2024
“enrollment milestone of 90 patients, which is expected to play as a major catalyst for the Company,” said Chris Seto
Dec 14 2023
“enrollment milestone of 90 patients, which is expected to play as a major catalyst for the Company,” said Chris Seto
Dec 4 2023
“our interim count of 90 patients, which is expected to play as a major catalyst for the Company.” Chris Seto
Nov 9 2023
“our interim count of 90 patients, which is expected to play as a major catalyst for the Company,” said Chris Seto
Nov 7 2023
“interim count of 90 patients, which is expected to play as a major catalyst for the Company,” said Chris Seto
Oct 3 2023
“with a view to enrolling our interim count of 90 patients, which is expected to play as a major catalyst for the Company,” said Chris Seto